Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

Publisher: Karger

E-ISSN: 1423-0232|84|3|158-165

ISSN: 0030-2414

Source: Oncology, Vol.84, Iss.3, 2012-12, pp. : 158-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract